# HL2351 CAPS Phase II Study

> **NCT02853084** · PHASE2 · TERMINATED · sponsor: **Handok Inc.** · enrollment: 8 (estimated)

## Conditions studied

- Cryopyrin-Associated Periodic Syndromes (CAPS)

## Interventions

- **DRUG:** HL2351

## Key facts

- **NCT ID:** NCT02853084
- **Lead sponsor:** Handok Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-10
- **Primary completion:** 2017-05
- **Final completion:** 2019-01
- **Target enrollment:** 8 (ESTIMATED)
- **Why stopped:** difficult of recruiting
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02853084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02853084, "HL2351 CAPS Phase II Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02853084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*